Minjie Wei

6.8k citations
83 papers · 5.5k indexed · 4 hit papers · h-index 30

Minjie Wei

81 papers receiving 5.3k citations

Hit Papers

Peptide–drug...133200220262010201850010001.5k

Peers

Minjie Wei
Comparison fields: 5 of 129
  • Pathology and Forensic Medicine 2.5k
  • Nephrology 703
  • Biological Psychiatry 202
  • Nutrition and Dietetics 1.1k
  • Orthopedics and Sports Medicine 491
Replace Hisanori Suzuki with:
Hisanori Suzuki Italy
Tiziana Genovese Italy
Raymond J. MacAllister United Kingdom
Catherine Vergely France
Dimitrios Th. Kremastinos Greece
Massimo Federici Italy
Katsumi Ikeda Japan
Meral Yüksel Türkiye
León Ferder Argentina
Tzong‐Shyuan Lee Taiwan
Minjie Wei relative to Hisanori Suzuki Italy Hisanori Suzuki's profile →
Citations per field
00.5×
Hisanori Suzuki · 1×
Citations per year

Countries citing papers authored by Minjie Wei

Since Specialization
Citations

This map shows the geographic impact of Minjie Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Minjie Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Minjie Wei more than expected).

Fields of papers citing papers by Minjie Wei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Minjie Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Minjie Wei. The network helps show where Minjie Wei may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Minjie Wei, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Minjie Wei Line = papers co-authored together Minjie Wei links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20251
2 20250
3 20246
4 20244
5 202426
6 202425
7 20237
8 202212
9 202123
10 20216
11 201911
12 201834
13 20161
14 201618
15 201536
16 201536
17 20134
18 20112
19 201081
20
1,25-Dihydroxyvitamin D3 is a negative endocrine regulator of the renin-angiotensin systembreakdown →
20021298

About Minjie Wei

Minjie Wei is a scholar working on Biological Psychiatry, Pathology and Forensic Medicine and Neurology, having authored 83 papers that have together received 5.5k indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (14 papers), DNA Repair Mechanisms (6 papers), Vitamin D Research Studies (6 papers), Neuroinflammation and Neurodegeneration Mechanisms (6 papers), Tryptophan and brain disorders (6 papers), Medicinal Plants and Neuroprotection (5 papers), BRCA gene mutations in cancer (4 papers) and Hormonal Regulation and Hypertension (4 papers). The work is most often cited by research in Pathology and Forensic Medicine (2.5k citations), Nephrology (703 citations) and Biological Psychiatry (202 citations). Minjie Wei has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Yan Chun Li, Juan Kong, Zhou‐Feng Chen, Liping Cao, Shu Q. Liu, Liping Cao, Mingyan Liu, Xin Zhong, Weifan Yao and Ke Du. Their work appears in journals such as Journal of Clinical Investigation, PLoS ONE and Cancer Cell.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026